TUMOR NECROSIS FACTOR ALPHA CONVERTASE

(19)

(11)

EP 0 900 272 A2

(12)

(43)	Date of publication:
	10.03.1999 Bulletin 1999/10

(21)	Application number: 97915426.0

(22)	Date of filing: 25.03.1997

(51)

International Patent Classification (IPC):

C12N 15/ 09^{( . )}
A61K 45/ 00^{( . )}
A61P 3/ 00^{( . )}
A61P 9/ 00^{( . )}
A61P 15/ 00^{( . )}
A61P 17/ 06^{( . )}
A61P 19/ 10^{( . )}
A61P 29/ 00^{( . )}
A61P 31/ 02^{( . )}
A61P 33/ 00^{( . )}
A61P 37/ 00^{( . )}
A61P 37/ 08^{( . )}
C07C 323/ 60^{( . )}
C07K 19/ 00^{( . )}
C12N 1/ 19^{( . )}
C12N 5/ 10^{( . )}
C12Q 1/ 37^{( . )}

A61K 31/ 00^{( . )}
A61P 1/ 00^{( . )}
A61P 3/ 10^{( . )}
A61P 9/ 10^{( . )}
A61P 17/ 00^{( . )}
A61P 19/ 00^{( . )}
A61P 25/ 00^{( . )}
A61P 31/ 00^{( . )}
A61P 31/ 18^{( . )}
A61P 33/ 06^{( . )}
A61P 37/ 06^{( . )}
A61P 43/ 00^{( . )}
C07D 513/ 04^{( . )}
C12N 1/ 15^{( . )}
C12N 1/ 21^{( . )}
C12N 9/ 64^{( . )}

(86)	International application number:
	PCT/EP1997/001497

(87)	International publication number:
	WO 1997/035538 (02.10.1997 Gazette 1997/42)

(84)	Designated Contracting States:
	AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30)

Priority:

26.03.1996 US 19960620663

(71)	Applicant: GLAXO GROUP LIMITED
	Greenford, Middlesex UB6 ONN (GB)

(72)

Inventors:

(74)	Representative: Reed, Michael Antony
	Intellectual Property Department Glaxo Wellcome plc Glaxo Wellcome House Berkeley Avenue Greenford, Middlesex UB6 0NN Greenford, Middlesex UB6 0NN (GB)

(54)	TUMOR NECROSIS FACTOR ALPHA CONVERTASE